Jean Marc Gombert

Title: Jean Marc Gombert: Innovator in Auto-Immune Disease Treatment

Introduction

Jean Marc Gombert is a notable inventor based in Poitiers, France. He has made significant contributions to the field of medical research, particularly in the treatment of auto-immune diseases. His innovative approach has led to the development of a unique pharmaceutical composition that utilizes interleukin 7.

Latest Patents

Jean Marc Gombert holds a patent for the "Use of IL-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular." This patent discloses the use of interleukin 7 or T cells pre-incubated in the presence of IL-7 for preparing a drug or pharmaceutical composition aimed at treating auto-immune diseases. This is particularly relevant for conditions induced by a defect in CD4+ T cell immunoregulation.

Career Highlights

Gombert's career is marked by his association with Sanofi-Synthelabo, a leading global healthcare company. His work there has focused on advancing therapeutic options for patients suffering from auto-immune disorders. His innovative research has positioned him as a key figure in the medical community.

Collaborations

Throughout his career, Jean Marc Gombert has collaborated with esteemed colleagues such as Jean Francois Bach and Andre Herbelin. These partnerships have fostered a collaborative environment that enhances the research and development of new treatments.

Conclusion

Jean Marc Gombert's contributions to the field of auto-immune disease treatment through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in this critical area of healthcare.